RABISIN, ενέσιμο εναιώρημα
RABISIN, ενέσιμο εναιώρημα
Ovlašten
- Rabies virus, strain G52, Inactivated
Identifikacija proizvoda
Naziv VMP-a:
RABISIN, ενέσιμο εναιώρημα
Djelatna tvar:
- Dostupno samo u English
Ciljne vrste životinja:
Način primjene:
-
Intramuskularno
-
Supkutano
Pojedinosti o proizvodu
Djelatna tvar i jačina:
-
Dostupno samo u English2.09log 10 optical density 501.00doza
Farmaceutski oblik:
-
suspenzija za injekciju
Withdrawal period by route of administration:
-
Intramuskularno
- Horse
-
Not applicableno withdrawal period
-
- Cattle
-
Not applicableno withdrawal period
-
- Sheep
-
Not applicableno withdrawal period
-
- Dog
-
Not applicableno withdrawal period
-
- Cat
-
Not applicableno withdrawal period
-
- Ferret
-
Not applicableno withdrawal period
-
-
Supkutano
- Cattle
-
Not applicableno withdrawal period
-
- Sheep
-
Not applicableno withdrawal period
-
- Dog
-
Not applicableno withdrawal period
-
- Cat
-
Not applicableno withdrawal period
-
- Ferret
-
Not applicableno withdrawal period
-
Kod anatomsko-terapijsko-kemijske klasifikacije (ATKvet kȏd):
- QI07AA02
Status odobrenja:
-
Važeće
Available in:
-
Greece
Dodatne informacije
Entitlement type:
-
Marketing Authorisation
Pravna osnova za odobrenje proizvoda:
- Dostupno samo u English
Nositelj odobrenja za stavljanje u promet:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Mjesta proizvodnje za izdavanje serije:
- Boehringer Ingelheim Animal Health France
Odgovorno tijelo:
- National Organization For Medicines
Broj autorizacije:
- 57429/02-06-2020/K-0013001
Datum promjene statusa odobrenja:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Koliko je bila korisna ova stranica?: